PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma.

Autor: Avilés-Salas A; Pathology Department, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Cabrera-Miranda L; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Hernández-Pedro N; Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Vargas-Lías DS; Pathology Department, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Samtani S; Medical Oncology Department, Clínica Las Condes Santiago, Santiago, Chile., Muñoz-Montaño W; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Motola-Kuba D; Departments of Biomedical Research and Gastroenterology and Liver Unit and Hemodialysis Unit, Medica Sur Clinic and Foundation, Mexico City, Mexico., Corrales-Rodríguez L; Medical Oncology Department, San Juan de Dios Hospital, San José, Costa Rica., Martín C; Department of Medicine, Western University, London, ON, Canada., Cardona AF; Thoracic Oncology Unit and Direction of Research, Science and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia.; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Palomares-Palomares CB; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico., Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Dec 04; Vol. 13, pp. 1269029. Date of Electronic Publication: 2023 Dec 04 (Print Publication: 2023).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Health-related quality of life in patients treated with pembrolizumab for microsatellite instability-high/mismatch repair-deficient advanced solid tumours: Results from the KEYNOTE-158 study.

Autor: Maio M; Center for Immuno-Oncology, University Hospital of Siena and University of Siena, Siena, Italy. Electronic address: maio@unisi.it., Amonkar MM; Merck & Co., Inc., Rahway NJ, USA. Electronic address: mayur.amonkar@merck.com., Norquist JM; Merck & Co., Inc., Rahway NJ, USA. Electronic address: josephine_norquist@merck.com., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: paolo.ascierto@gmail.com., Manzyuk L; NN Blokhin National Medical Research Center of Oncology, Moscow, Russia. Electronic address: l.manzyuk@gmail.com., Motola-Kuba D; COMOP A.C., Clinical Investigation, Mexico City, Mexico. Electronic address: danielmotola@gmail.com., Penel N; Centre Oscar Lambret and Lille University, Lille, France. Electronic address: n-penel@o-lambret.fr., Cassier PA; Department of Medical Oncology, Centre Léon Bérard, Lyon, France. Electronic address: philippe.cassier@lyon.unicancer.fr., Bariani GM; Instituto Do Câncer Do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil. Electronic address: bariani@yahoo.com., De Jesus Acosta A; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. Electronic address: adejesu1@jhmi.edu., Doi T; National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: doi.toshi@gmail.com., Longo F; Hospital Universitario Ramón y Cajal, IRYCIS, CIBERONC, Madrid, Spain. Electronic address: fedelongomunoz@hotmail.com., Miller WH Jr; Jewish General Hospital and McGill University, Montréal, QC, Canada. Electronic address: wilsonmiller@gmail.com., Oh DY; Department of Internal Medicine, Seoul National University Hospital, and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: ohdoyoun@snu.ac.kr., Gottfried M; Meir Medical Center, Tel Aviv, Israel. Electronic address: maya.gottfried@clalit.org.il., Wang R; Merck & Co., Inc., Rahway NJ, USA. Electronic address: ruixue.wang@merck.com., Norwood K; Merck & Co., Inc., Rahway NJ, USA. Electronic address: kevin.norwood@merck.com., Marabelle A; Gustave Roussy, INSERM U1015 and CIC1418, Université Paris Saclay, Villejuif, France. Electronic address: AURELIEN.MARABELLE@gustaveroussy.fr.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jul; Vol. 169, pp. 188-197. Date of Electronic Publication: 2022 May 16.

Acute Cardiac Tamponade Secondary to Cardiac Vascular-Type Pleomorphic Leiomyosarcoma: Case Report.

Autor: Fernández-Ferreira R; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Soberanis-Piña PD; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Conde-Flores E; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Arroyave-Ramírez AM; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Mackinney-Novelo I; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Motola-Kuba D; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Ruiz-Morales JM; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Alvarado-Luna G; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Chable-Montero F; Service of Anatomical Pathology, Medica Sur Clinic & Foundation, Mexico City, Mexico.

Publikováno v: Case reports in oncology [Case Rep Oncol] 2021 Dec 30; Vol. 14 (3), pp. 1860-1867. Date of Electronic Publication: 2021 Dec 30 (Print Publication: 2021).

Epithelial-Cadherin Expression Is Associated With Better Recurrence-Free and Overall Survival in Invasive Lobular Breast Cancer in Mexican Women.

Autor: Fernandez-Ferreira R; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Dorantes-Heredia R; Service of Anatomical Pathology, Medica Sur Clinic & Foundation, Mexico City, Mexico., Motola-Kuba D; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Ruiz-Morales JM; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Alvarado-Luna G; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Kinney-Novelo IM; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Munoz-Montano WR; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico., Fuentes-Calvo KJ; Oncology Medicine Department, Comprehensive Oncology Center 'Diana Laura Riojas de Colosio', Medica Sur Clinic & Foundation, Mexico City, Mexico.

Publikováno v: World journal of oncology [World J Oncol] 2021 Dec; Vol. 12 (6), pp. 214-224. Date of Electronic Publication: 2021 Dec 28.